Prolytix Email Format
Biotechnology ResearchVermont, United States11-50 Employees
Prolytix is a biotechnology research company with more than three decades of experience in protein chemistry, enabling it to address the challenges associated with large-molecule therapies. Its services span research and development, characterization by high-resolution mass spectrometry, GxP testing, and custom collection devices for clients worldwide. It supports product development from discovery through GMP release, drawing on regulatory and CMC expertise spanning IND to BLA. Based in Essex Junction, Vermont, Prolytix—formerly Haematologic Technologies—operates with a small to mid-sized team and serves clients globally in the biotechnology sector focused on protein therapeutics. A notable development is a 2024 long-term strategic collaboration with Allumiqs Corporation to accelerate discovery and development of new drugs.